Navamedic ASA (NAVA) - Total Liabilities
Based on the latest financial reports, Navamedic ASA (NAVA) has total liabilities worth Nkr407.67 Million NOK (≈ $42.90 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Navamedic ASA - Total Liabilities Trend (2003–2025)
This chart illustrates how Navamedic ASA's total liabilities have evolved over time, based on quarterly financial data. See NAVA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Navamedic ASA Competitors by Total Liabilities
The table below lists competitors of Navamedic ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Inventus Mining Corp
V:IVS
|
Canada | CA$1.14 Million |
|
Modernform Group Public Company Limited
BK:MODERN
|
Thailand | ฿915.68 Million |
|
Metagenomi, Inc. Common Stock
NASDAQ:MGX
|
USA | $59.17 Million |
|
Obase Bilgisayar ve Danismanlik Hizmetleri Ticaret A.S.
IS:OBASE
|
Turkey | TL322.75 Million |
|
AXIOS Sustainable Growth
NYSE:AXAC
|
USA | $1.18 Million |
|
Idex ASA
OL:IDEX
|
Norway | Nkr5.55 Million |
|
Duck Yang Ind
KO:024900
|
Korea | ₩452.87 Billion |
|
SunCar Technology Group Inc.
NASDAQ:SDA
|
USA | $162.51 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Navamedic ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Navamedic ASA market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.40 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Navamedic ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Navamedic ASA (2003–2025)
The table below shows the annual total liabilities of Navamedic ASA from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Nkr407.67 Million ≈ $42.90 Million |
+62.55% |
| 2024-12-31 | Nkr250.81 Million ≈ $26.39 Million |
-16.93% |
| 2023-12-31 | Nkr301.91 Million ≈ $31.77 Million |
+74.46% |
| 2022-12-31 | Nkr173.05 Million ≈ $18.21 Million |
-3.29% |
| 2021-12-31 | Nkr178.94 Million ≈ $18.83 Million |
+37.07% |
| 2020-12-31 | Nkr130.55 Million ≈ $13.74 Million |
+21.08% |
| 2019-12-31 | Nkr107.83 Million ≈ $11.35 Million |
-6.57% |
| 2018-12-31 | Nkr115.41 Million ≈ $12.14 Million |
-23.35% |
| 2017-12-31 | Nkr150.57 Million ≈ $15.84 Million |
-17.24% |
| 2016-12-31 | Nkr181.94 Million ≈ $19.15 Million |
+15.68% |
| 2015-12-31 | Nkr157.27 Million ≈ $16.55 Million |
+54.23% |
| 2014-12-31 | Nkr101.97 Million ≈ $10.73 Million |
+41.19% |
| 2013-12-31 | Nkr72.22 Million ≈ $7.60 Million |
+94.80% |
| 2012-12-31 | Nkr37.07 Million ≈ $3.90 Million |
-19.11% |
| 2011-12-31 | Nkr45.83 Million ≈ $4.82 Million |
+98.24% |
| 2010-12-31 | Nkr23.12 Million ≈ $2.43 Million |
-6.65% |
| 2009-12-31 | Nkr24.77 Million ≈ $2.61 Million |
-49.86% |
| 2008-12-31 | Nkr49.40 Million ≈ $5.20 Million |
-12.51% |
| 2007-12-31 | Nkr56.46 Million ≈ $5.94 Million |
-768.93% |
| 2006-12-31 | Nkr-8.44 Million ≈ $-888.25K |
-275.64% |
| 2005-12-31 | Nkr4.81 Million ≈ $505.74K |
-347.21% |
| 2004-12-31 | Nkr-1.94 Million ≈ $-204.58K |
-69.81% |
| 2003-12-31 | Nkr-6.44 Million ≈ $-677.59K |
-- |
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition… Read more